Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.
Smeland S, et al.
Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.
Eur J Cancer. 2019.
PMID: 30685685
Free PMC article.
Clinical Trial.
BACKGROUND: High-grade osteosarcoma is a primary malignant bone tumour mainly affecting children and young adults. ...METHODS: Patients eligible for EURAMOS-1 were aged 40 years with M0 or M1 skeletal high-grade osteosarcoma in which case complete surgical resection …
BACKGROUND: High-grade osteosarcoma is a primary malignant bone tumour mainly affecting children and young adults. ...METHODS: Patien …